Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Different phenotypes for phenylalanine hydroxylase deficiency

F Güttler, G Hansen

    Annals of Clinical Biochemistry
    |May 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    scRNA-seq reveals persistent aberrant differentiation of nasal epithelium driven by TNFα and TGFβ in post-COVID syndrome.

    Nature communications·2025
    Same author

    Increased breath naphthalene in children with asthma and wheeze of the All Age Asthma Cohort (ALLIANCE).

    Journal of breath research·2023
    Same author

    An examination of mercury levels in the coastal environment and fish of Cote d'Ivoire.

    Chemosphere·2022
    Same author

    Commentary: Physical activity after patent foramen ovale (PFO)-associated stroke: a personal narrative and call to action.

    Topics in stroke rehabilitation·2022
    Same author

    Cytokine levels in children and adults with wheezing and asthma show specific patterns of variability over time.

    Clinical and experimental immunology·2020
    Same author

    Forensic postmortem computed tomography in suspected unnatural adult deaths.

    European journal of radiology·2020
    Same journal

    Limitations of spectrophotometry in the analysis of cerebrospinal fluid bilirubin.

    Annals of clinical biochemistry·2026
    Same journal

    Commentary on the impact of lithium heparin vacutainer tubes on daily cerebrospinal fluid analysis.

    Annals of clinical biochemistry·2026
    Same journal

    Routine laboratory triage for NT-proBNP elevation may reflect cardiorenal frailty as much as heart failure specificity.

    Annals of clinical biochemistry·2026
    Same journal

    From interpretable NT-proBNP prediction to equitable laboratory stewardship.

    Annals of clinical biochemistry·2026
    Same journal

    Serum Sclerostin Levels in Children with Osteogenesis Imperfecta.

    Annals of clinical biochemistry·2026
    Same journal

    Population-Specific HOMA-IR Reference Ranges in Iraq: Defining Insulin Sensitivity in a Middle Eastern Cohort.

    Annals of clinical biochemistry·2026
    See all related articles

    Phenylketonuria (PKU) and hyperphenylalaninemia (HPA) are classified into three phenotypes. A novel discriminant accurately distinguishes heterozygous phenotypes, correlating parental and child phenotypes.

    Area of Science:

    • Biochemistry
    • Genetics
    • Metabolic Disorders

    Background:

    • Abnormalities in phenylalanine hydroxylation lead to phenylketonuria (PKU) and hyperphenylalaninemia (HPA).
    • These conditions are phenotypically classified based on dietary phenylalanine tolerance and serum phenylalanine levels.
    • Therapeutic serum phenylalanine levels are defined as 180-425 µmol/L.

    Purpose of the Study:

    • To classify phenylalanine hydroxylation abnormalities into distinct phenotypes.
    • To evaluate a novel discriminant for distinguishing heterozygous phenotypes.
    • To investigate the correlation between parental and child phenotypes in PKU/HPA.

    Main Methods:

    • Oral phenylalanine loading was administered to 100 heterozygotes and 33 normal homozygotes.

    Related Experiment Videos

  • A discriminant function was calculated using serum tyrosine and phenylalanine concentrations post-loading.
  • Statistical analysis was employed to assess phenotypic distinctions and correlations.

    • Main Results:

    • The discriminant (slope of tyrosine rise * max tyrosine / max phenylalanine) effectively distinguished phenotypes with minimal overlap (2.4%).
    • Three distinct heterozygous phenotypes were identified using this discriminant.
    • A significant correlation was found between parental and affected child phenotypes, particularly distinguishing classical PKU parents.

    Conclusions:

    • The developed discriminant is a powerful tool for classifying heterozygous PKU/HPA phenotypes.
    • This method aids in understanding the genetic transmission of these metabolic disorders.
    • Accurate phenotypic classification is crucial for genetic counseling and management of PKU/HPA.